Next, we combined two drugs LGK974 and trametinib to treat CRC PDXs in NCG mice to assess the therapeutic potential of targeting Wnt-EIF3H pathways (Fig. 7c). The gene discussed is EIF3H; the disease is colorectal carcinoma.